Here's Evo! This Singaporean D2C startup just raised a $600,000 seed led by East Ventures.

• Founded in 2020, they broke even in June this year and aim to hit 8-digit annualized revenue by the end of 2022.
• They've hit 700% growth in the last five months and operate in ten markets.

Investor check. Their investors include Bonjour Holdings, SparkLabs Ventures, Paragon Capital, Farquhar Capital, Aaron Tan (Co-founder and CEO, Carro), Joel Leong (Co-founder, ShopBack) Mohandass Kalaichelvan (Co-founder and CEO, Spenmo) and Jonathan Tan (Founder and MD, PRISM+).

‍

🔠 ABCs on Evo

They're a house of brands focused on health and beauty products.

• They manufacture in the same factories as global megabrands, so their products are high-quality for less $$$.
• Going D2C removes the inefficiencies and costs of traditional retail and distribution.

‍

💊 Spill the pills

Right now, they have over eight products, including their flagship liver care and hangover cure BounceBack, anti-hair loss brand MANTOU and supplements for sleep, hair health and immunity under stryv.

‍

💰 What's with the $$$?

They'll be expanding the brand's product offerings, doubling down on R&D for new product categories and exploring new distribution brands in D2C.